Propeller Health, the leading digital health solution for respiratory medicine, today announced a partnership with Aptar Pharma (Aptar), a global drug delivery systems provider, including technology for metered dose inhalers systems (MDIs) for treatment of asthma and chronic obstructive pulmonary disease (COPD).
Under the terms of the agreement, Propeller and Aptar will jointly develop the world’s first fully-integrated connected MDI (cMDI), with an integrated sensor and a novel electronic dose counter. The device is currently available for licensing and is expected to enter clinical studies later this year.
About Aptar Pharma
Aptar Pharma is a part of the AptarGroup family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage.
AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables,
food, and beverage markets.
AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia and South America.
To learn more, visit www.aptar.com/pharma.
Tel.: +1 917 509 5399